Stock Screener App

Gratuito -

Installare

0.108

1.82% -0.002

Cns Pharmaceuticals Inc (CNSP)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Cns Pharmaceuticals Inc Azioni (CNSP) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	34.10% 3.5449	5.3794	4.5338	4.0254	4.9265
Interest Income/Expense	129.95% 0.00663	0.00288	0.00184	0.00365	0.00544
Operating Income/Loss	34.10% -3.5449	-5.3794	-4.5338	-4.0254	-4.9265
Nonoperating Income/Loss	97.43% 0.000106	0.00412	0.011	0.00415	-0.00544
Income/Loss From Continuing Operations Before Tax	34.05% -3.5447	-5.3753	-4.5228	-4.0212	-4.9319
Income/Loss From Continuing Operations After Tax	34.05% -3.5447	-5.3753	-4.5228	-4.0212	-4.9319
Net Income/Loss	34.05% -3.5447	-5.3753	-4.5228	-4.0212	-4.9319
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,881% 8.7127	0.4397	4.1771	3.8773	1.9065
Diluted Average Shares	1,881% 8.7127	0.4397	4.1771	3.8773	1.9065
Basic Earnings Per Share	56.84% -0.41	-0.95	-1.08	-1.04	-2.59
Diluted Earnings Per Share	56.84% -0.41	-0.95	-1.08	-1.04	-2.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters